NUS (NuSkin Enterprises, Inc.) Stock Analysis - AI Report
NuSkin Enterprises, Inc. (NUS) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, NUS trades at $5.84 with a market cap of $284.51M and a P/E ratio of 5.18. NUS moved +2.46% today. Year to date, NUS is -39.73%; over the trailing twelve months it is -23.06%. Its 52-week range spans $5.32 to $14.62. Rallies surfaces NUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on NUS?
Rallies AI research for NUS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
Nathanson Laura sold 2.68K (~$18.01K) on May 11, 2026.
Hatchett Steven Keith bought 5.50K (~$52.85K) on Nov 11, 2025.
Nathanson Laura sold 6.49K (~$79.30K) on Sep 4, 2025.
NUS Analyst Consensus
NUS analyst coverage data. Average price target: $0.00.
Common questions about NUS
What is the AI research view on NUS?
Rallies AI research for NUS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for NUS?
Rallies AI research for NUS combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is NUS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NUS. It does not provide personalized investment advice.
